0001574774-18-000015.txt : 20180314
0001574774-18-000015.hdr.sgml : 20180314
20180314182558
ACCESSION NUMBER: 0001574774-18-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180313
FILED AS OF DATE: 20180314
DATE AS OF CHANGE: 20180314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Broadway Fred
CENTRAL INDEX KEY: 0001557180
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55039
FILM NUMBER: 18690605
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 210
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTELEMETRY, INC.
CENTRAL INDEX KEY: 0001574774
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 462568498
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 CEDAR HOLLOW ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-729-7000
MAIL ADDRESS:
STREET 1: 1000 CEDAR HOLLOW ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: BioTelemetry, Inc.
DATE OF NAME CHANGE: 20130418
4
1
wf-form4_152106634468346.xml
FORM 4
X0306
4
2018-03-13
0
0001574774
BIOTELEMETRY, INC.
BEAT
0001557180
Broadway Fred
1000 CEDAR HOLLOW RD. SUITE 102
MALVERN
PA
19355
0
1
0
0
President BioTel Heart
Common Stock
2018-03-13
4
M
0
40000
16.59
A
64880
D
Common Stock
2018-03-13
4
M
0
10000
6.95
A
74880
D
Common Stock
2018-03-13
4
M
0
4158
8.79
A
79038
D
Common Stock
2018-03-13
4
S
0
54158
34.17
D
24880
D
Stock Options (Right to Buy)
16.59
2018-03-13
4
M
0
40000
0
D
2019-06-29
Common Stock
40000.0
0
D
Stock Options (Right to Buy)
6.95
2018-03-13
4
M
0
10000
0
D
2019-08-12
Common Stock
10000.0
0
D
Stock Options (Right to Buy)
8.79
2018-03-13
4
M
0
4158
0
D
2020-05-10
Common Stock
4158.0
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.70 to $35.60, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The stock options vested in four equal annual installments which began on December 31, 2009. The options were fully exercisable as of December 31, 2012.
The stock options vested in four equal annual installments which began on December 31, 2010. The options were fully exercisable as of December 31, 2013.
/s/ Peter F. Ferola, Attorney-in-Fact
2018-03-14